251 related articles for article (PubMed ID: 15837318)
1. Solid-phase synthesis and antibacterial evaluations of N-demethylvancomycin derivatives.
Yao NH; Liu G; He WY; Niu C; Carlson JR; Lam KS
Bioorg Med Chem Lett; 2005 May; 15(9):2325-9. PubMed ID: 15837318
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity against Clostridium difficile of novel demethylvancomycin derivatives.
Zhang SJ; Yang Q; Xu L; Chang J; Sun X
Bioorg Med Chem Lett; 2012 Aug; 22(15):4942-5. PubMed ID: 22765891
[TBL] [Abstract][Full Text] [Related]
4. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
Lohray BB; Lohray VB; Srivastava BK; Kapadnis PB; Pandya P
Bioorg Med Chem; 2004 Sep; 12(17):4557-64. PubMed ID: 15358283
[TBL] [Abstract][Full Text] [Related]
5. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin.
Plattner JJ; Chu D; Mirchink EP; Isakova EB; Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Printsevskaya SS
J Antibiot (Tokyo); 2007 Apr; 60(4):245-50. PubMed ID: 17456974
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a novel series of semisynthetic vancomycin derivatives effective against vancomycin-resistant bacteria.
Nakama Y; Yoshida O; Yoda M; Araki K; Sawada Y; Nakamura J; Xu S; Miura K; Maki H; Arimoto H
J Med Chem; 2010 Mar; 53(6):2528-33. PubMed ID: 20180534
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial activity of O-substituted nocathiacin I derivatives.
Naidu BN; Sorenson ME; Hudyma T; Zheng X; Zhang Y; Bronson JJ; Pucci MJ; Clark JM; Ueda Y
Bioorg Med Chem Lett; 2004 Jul; 14(14):3743-6. PubMed ID: 15203154
[TBL] [Abstract][Full Text] [Related]
8. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers.
Griffin JH; Linsell MS; Nodwell MB; Chen Q; Pace JL; Quast KL; Krause KM; Farrington L; Wu TX; Higgins DL; Jenkins TE; Christensen BG; Judice JK
J Am Chem Soc; 2003 May; 125(21):6517-31. PubMed ID: 12785792
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of nocathiacin I analogues.
Naidu BN; Sorenson ME; Matiskella JD; Li W; Sausker JB; Zhang Y; Connolly TP; Lam KS; Bronson JJ; Pucci MJ; Yang H; Ueda Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3545-9. PubMed ID: 16621551
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic activities and affinities for bacterial cell wall analogue of N-demethylvancomycin and its derivatives.
Yan H; Qi D; Cheng X; Song Z; Li W; He B
J Antibiot (Tokyo); 1998 Aug; 51(8):750-6. PubMed ID: 9766467
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria.
Lu J; Yoshida O; Hayashi S; Arimoto H
Chem Commun (Camb); 2007 Jan; (3):251-3. PubMed ID: 17299629
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial activities of chiral 1,3-oxazinan-2-one derivatives.
Wang G; Ella-Menye JR; Sharma V
Bioorg Med Chem Lett; 2006 Apr; 16(8):2177-81. PubMed ID: 16495055
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-antibacterial activity relationship investigation of isomeric 2,3,5-substituted perhydropyrrolo[3,4-d]isoxazole-4,6-diones.
Agirbas H; Guner S; Budak F; Keceli S; Kandemirli F; Shvets N; Kovalishyn V; Dimoglo A
Bioorg Med Chem; 2007 Mar; 15(6):2322-33. PubMed ID: 17276071
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of caprazamycin analogues and their structure--activity relationship for antibacterial activity.
Hirano S; Ichikawa S; Matsuda A
J Org Chem; 2008 Jan; 73(2):569-77. PubMed ID: 18092805
[TBL] [Abstract][Full Text] [Related]
15. Elucidation of the active conformation of vancomycin dimers with antibacterial activity against vancomycin-resistant bacteria.
Nakamura J; Yamashiro H; Hayashi S; Yamamoto M; Miura K; Xu S; Doi T; Maki H; Yoshida O; Arimoto H
Chemistry; 2012 Oct; 18(40):12681-9. PubMed ID: 22915313
[TBL] [Abstract][Full Text] [Related]
16. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
[TBL] [Abstract][Full Text] [Related]
17. Novel pyridazine derivatives: Synthesis and antimicrobial activity evaluation.
Kandile NG; Mohamed MI; Zaky H; Mohamed HM
Eur J Med Chem; 2009 May; 44(5):1989-96. PubMed ID: 19013692
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and in vitro antibacterial activities of new 3,5-disubstituted oxazolidinone compounds].
Meng QG; Wang Q; Liu J
Yao Xue Xue Bao; 2003 Oct; 38(10):754-9. PubMed ID: 14730898
[TBL] [Abstract][Full Text] [Related]
19. Nocathiacin I analogues: synthesis, in vitro and in vivo biological activity of novel semi-synthetic thiazolyl peptide antibiotics.
Naidu BN; Sorenson ME; Zhang Y; Kim OK; Matiskella JD; Wichtowski JA; Connolly TP; Li W; Lam KS; Bronson JJ; Pucci MJ; Clark JM; Ueda Y
Bioorg Med Chem Lett; 2004 Nov; 14(22):5573-7. PubMed ID: 15482927
[TBL] [Abstract][Full Text] [Related]
20. [Recent advances in the study of synthesis and activity of vancomycin derivatives].
Chen YY; Liu G
Yao Xue Xue Bao; 2007 May; 42(5):463-9. PubMed ID: 17703765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
